ARVINAS, INC. Accretion Expense
ARVINAS, INC. (ARVN) reported Accretion Expense of $5.38 thousand for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AccretionExpense · last filed 2019-05-09
- ARVINAS, INC. accretion expense for the quarter ending 2019-03-31 was $5.38K, a 84.73% decline year-over-year.
- ARVINAS, INC. accretion expense for the quarter ending 2018-12-31 was $34.88K, a 10.56% increase year-over-year.
- ARVINAS, INC. accretion expense for the quarter ending 2018-03-31 was $35.25K.
- ARVINAS, INC. accretion expense for the quarter ending 2017-12-31 was $31.55K.
- ARVINAS, INC. accretion expense for fiscal 2018 was $248.07K, a 27.91% decline from fiscal 2017.
- ARVINAS, INC. accretion expense for fiscal 2017 was $344.11K.
| Period end | Accretion Expense 3 month | Accretion Expense 6 month | Accretion Expense 9 month | Accretion Expense 12 month |
|---|---|---|---|---|
| 2019-03-31 | $5.38K 10-Q · filed 2019-05-09 | $40.26K derived: sum of 2 quarters · filed 2019-05-09 | ||
| 2018-12-31 | $34.88K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | $248.07K 10-K · filed 2019-03-26 | ||
| 2018-09-30 | $213.19K 10-Q · filed 2018-11-14 | |||
| 2018-03-31 | $35.25K 10-Q · filed 2019-05-09 | $66.80K derived: sum of 2 quarters · filed 2019-05-09 | ||
| 2017-12-31 | $31.55K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | $344.11K 10-K · filed 2019-03-26 | ||
| 2017-09-30 | $312.56K 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |